Companies in the therapeutics sector developing innovative solutions and technologies.
Explore 1,708 recently funded therapeutics companies with verified founder contact information and fundraising data.
Outlook Therapeutics is a biopharmaceutical company that develops ophthalmic formulations.
Maze Therapeutics is a biotechnology company that develops precision medicines for renal, cardiovascular, and metabolic diseases.
Biovitae focuses on infection control and prevention, as well as combating antimicrobial resistance.
CERo Therapeutics, Inc. is a new cellular immunotherapy company.
Cyto-Facto is a biotechnology company that develops and manufactures CAR-T cell therapies and mesenchymal stem cell products.
Invea Therapeutics focuses on the discovery of transformational therapeutics for inflammatory gastrointestinal and hepatobiliary disorders.
Ray Therapeutics is a biotech company that develops optogenetic gene therapies for patients with blinding diseases.
Prelude Therapeutics designs and develops small molecule therapies targeting key drivers of cancer cell growth and resistance.
ReviR Therapeutics is a genomics-based platform that develops novel medicines targeting human RNAs.
Brainjo uses virtual reality (VR) and brain-computer interfaces for treating ADHD, providing a modern approach to mental health care.
Irras is a commercial-stage medical technology company.
Ventus Therapeutics develops small molecule drugs that target autoimmune diseases, inflammatory diseases, and cancer.
Outrun TX develops a platform for the identification of therapeutics that selectively target the protein degradation pathway.
Ariceum Therapeutics focuses on diagnosis and precision treatment of neuroendocrine and certain other aggressive, hard-to-treat cancers.
Bonum Therapeutics creates a technology platform to treat a wide range of diseases.
Orthogon Therapeutics is a drug development company developing antiviral drugs for immune-suppressed patients.
Allegria Therapeutics is a biotech firm that engages in the research and treatment of allergy and mast cell-mediated inflammatory diseases.
Alia Therapeutics is developing next-generation gene-editing medicines to cure rare genetic diseases.
Mozarc Medical is a medical device manufacturing company that focuses on developing innovative technologies for kidney health.
Storm Therapeutics develops small-molecule therapies that target RNA-modifying enzymes to treat cancer and other diseases.
Onward develops an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools.
Acurx Pharmaceuticals is a clinical stage biopharmaceutical company focused on developing new antibiotics for difficult to treat infections.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
MeiraGTx is a biotechnology company that focuses on developing gene therapies to treat inherited and acquired genetic disorders.
Glycomine is an early-stage biotech working on replacement therapies for rare diseases.
The therapeutics sector is an active area of startup innovation and venture capital investment. Companies in this space are developing new technologies, platforms, and services that address evolving market needs and create new business opportunities.
Therapeutics companies raise capital across various funding stages, from early seed rounds to late-stage growth financing. Investor interest in this sector is driven by the size of the addressable market, the pace of technology adoption, and the potential for scalable business models.
The therapeutics sector is expected to continue evolving as technology advances, market dynamics shift, and new opportunities emerge. Companies that demonstrate strong product-market fit, efficient growth, and clear competitive advantages are well-positioned to attract continued investment.
Here is how funding is distributed among the 1,708 therapeutics companies tracked in the VCBacked database.
Companies in the therapeutics sector often overlap with or complement businesses in adjacent industries. Exploring related verticals can help you discover additional companies, identify partnership opportunities, and understand the broader competitive landscape.
Perfect for: B2B sales teams targeting therapeutics companies, investors exploring sector opportunities, and service providers looking for funded companies ready to scale.
Get Started - Access Contact InformationJoin thousands of sales teams, investors, and service providers using VCBacked